2018 Pharma Choice Unbranded Bronze Winner NAVICOR and Celgene Corporation

NAVICOR

Celgene Corporation

Celgene “Chemosaurus”

Chemotherapy, a backbone of indolent non-Hodgkin’s lymphoma therapy for more than 50 years, has not evolved to match recent improved understanding of iNHL. Celgene is focused on therapies that allow cancer patients to thrive during treatment, virtually rendering chemotherapy extinct.

Agency Team:

Managing Director, Executive Creative Director: Marvin J. Bowe, III
VP, Creative Director: James A. Griffith II
ACD, Copy: Tom Ferrara
ACD, Art: Ana Ferreira
Sr. Art Director: John Catania
Sr. Art Director: Monica Ibarra
Design & Fabrication Firm: Creative Machines
CGI Artist: Taylor James

Ads

You May Also Like

PM360 2019 Trailblazer Awards Sales Aid Winner Boehringer Inhgelheim and Confideo Labs

SPIRIVA RESPIMAT 360 VR MOA Sales Aid (Boehringer Inhgelheim, Confideo Labs) Boehringer Ingelheim teamed ...

The Future of Computing—A Preview

Held annually in Taipei, Taiwan, COMPUTEX is considered to be the biggest computing event ...

PM360 2021 Trailblazer Awards Product/Service Launch Gold Winner Gilead-Kite Oncology and Brick City Greenhouse

Trodelvy, “Trojan Horse” (Gilead-Kite Oncology, Brick City Greenhouse) Metastatic triple-negative breast cancer (mTNBC) is ...